HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Invested Capital (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Invested Capital came in at $1.4 billion in Q2 2026, up 2.55% year-over-year from $1.3 billion in Q2 2025, and up 1.86% quarter-over-quarter from $1.3 billion in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Invested Capital (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Invested Capital for 12 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Invested Capital rose 2.55% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 2.55% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, changed N/A from the prior year.
  • Invested Capital was $1.4 billion for Q2 2026 at HUTCHMED (China), up from $1.3 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $1.4 billion in Q2 2026 and troughed at $675.2 million in Q4 2022.
  • A 5-year average of $1.0 billion and a median of $854.3 million in 2022 frame the typical range for Invested Capital.
  • Across the five-year window, Invested Capital sank 36.8% in 2022 and surged 60.09% in 2025, its largest moves.
  • Over 5 years, Invested Capital stood at $675.2 million in 2022, then advanced by 24.73% to $842.1 million in 2023, then fell by 0.95% to $834.1 million in 2024, then soared by 61.18% to $1.3 billion in 2025, then grew by 1.86% to $1.4 billion in 2026.
  • The last three Invested Capital figures came in at $1.4 billion (Q2 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn 74.44 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn 40.49 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn 33.70 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn -
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn 7.35 Bn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn -
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn 26.94 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn -
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - 1.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.37 Bn
Dec 31, 2025 1.34 Bn
Jun 30, 2025 1.34 Bn
Jun 30, 2024 834.12 Mn
Jun 30, 2023 842.12 Mn
Dec 31, 2022 675.18 Mn
Jun 30, 2022 854.33 Mn
Dec 31, 2021 1.07 Bn
Jun 30, 2021 1.04 Bn
Mar 31, 2021 455.14 Mn
Dec 31, 2020 573.07 Mn
Jun 30, 2020 393.89 Mn
Dec 31, 2019 340.09 Mn
Sep 30, 2019 339.28 Mn
Jun 30, 2019 375.83 Mn
Mar 31, 2019 434.54 Mn
Dec 31, 2018 445.26 Mn
Jun 30, 2018 495.22 Mn
Dec 31, 2017 515.42 Mn
Jun 30, 2017 263.75 Mn